Literature DB >> 15529358

Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus.

Hiroshi Okamoto1, Yasuhiro Katsumata, Katsuji Nishimura, Naoyuki Kamatani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15529358     DOI： 10.1002/art.20598

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  15 in total

1.  Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.

Authors:  E Sato; N Iikuni; T Yoshio; S Minota; N Kamatani; H Okamoto
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

2.  Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.

Authors:  N Iikuni; H Okamoto; T Yoshio; E Sato; S Kamitsuji; T Iwamoto; S Momohara; A Taniguchi; H Yamanaka; S Minota; N Kamatani
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

3.  Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors.

Authors:  Hilda Fragoso-Loyo; Javier Cabiedes; Yvonne Richaud-Patin; Alejandro Orozco-Narváez; Betty Diamond; Luis Llorente; Jorge Sánchez-Guerrero
Journal:  Rheumatology (Oxford)       Date:  2009-09-15       Impact factor: 7.580

4.  SLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection.

Authors:  Patrick O'Connell; Yuliya Pepelyayeva; Maja K Blake; Sean Hyslop; Robert B Crawford; Michael D Rizzo; Cristiane Pereira-Hicks; Sarah Godbehere; Linda Dale; Peter Gulick; Norbert E Kaminski; Andrea Amalfitano; Yasser A Aldhamen
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

Review 5.  Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.

Authors:  Hiroshi Okamoto; Akiko Kobayashi; Hisashi Yamanaka
Journal:  J Biomed Biotechnol       Date:  2010-06-29

6.  A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE.

Authors:  Matilda W Nicholas; Mary Anne Dooley; Susan L Hogan; Jennifer Anolik; John Looney; Ingnacio Sanz; Stephen H Clarke
Journal:  Clin Immunol       Date:  2008-02       Impact factor: 3.969

7.  Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli; E D Tate; N R McGee; A L Travelstead; S J Verhulst; R M Ransohoff
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

8.  Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus.

Authors:  Stephen H Clarke
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.

Authors:  Deanna M Santer; Taku Yoshio; Seiji Minota; Thomas Möller; Keith B Elkon
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  Macrophages induce differentiation of plasma cells through CXCL10/IP-10.

Authors:  Wei Xu; HyeMee Joo; Sandra Clayton; Melissa Dullaers; Marie-Cecile Herve; Derek Blankenship; Maria Teresa De La Morena; Robert Balderas; Capucine Picard; Jean-Laurent Casanova; Virginia Pascual; SangKon Oh; Jacques Banchereau
Journal:  J Exp Med       Date:  2012-09-17       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.